Replimune REPL
NASDAQ REPL
$13.45 +0.21 (+1.59%)
At close: Oct 1, 2026 · 4:00 PM EDT

Replimune (REPL) Change in Accured Expenses (2017 - 2026)

Updated

Replimune (REPL) reported Change in Accured Expenses of -$17.42 million for fiscal Q1 2027 (quarter ended Jun 30, 2026), compared with -$5.54 million a year earlier.

Analysis

Replimune (REPL) Change in Accured Expenses (2017 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Replimune's Change in Accured Expenses came in at -$9.7 million; for FY2026 (ended Mar 31, 2026), it was $2.18 million, down 81.4% from FY2025.

  • Change in Accured Expenses has a five-year compound annual growth rate of -8.5% (FY2021 to FY2026).
  • By fiscal year, Change in Accured Expenses came in at $11.74 million in FY2025 (+27.2%), $9.23 million in FY2024 (-18.8%), $11.38 million in FY2023 (+140.8%) and $4.73 million in FY2022 (+38.4%).
  • The fiscal Q1 2027 figure ranks as the lowest quarterly Change in Accured Expenses in data going back to fiscal Q1 2018.
  • Year over year, Change in Accured Expenses gained in two of the last four quarters, with growth averaging 165.1%.
  • The high point for year-over-year Change in Accured Expenses in five years was fiscal Q2 2026 (growth of 584.0%); the low point was fiscal Q2 2025 (a decline of 95.1%).
  • Per Business Quant data, the three fiscal quarters before Q1 2027 came in at $6.86 million (Q4 2026), -$1.91 million (Q3 2026) and $2.77 million (Q2 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Accured Exp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 2.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 1.20 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -251.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 901.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 338.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 222.50 Mn
10 Replimune 1.11 Bn 1.11 Bn - -17.42 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.42 Mn
Mar 31, 2026 6.86 Mn
Dec 31, 2025 -1.91 Mn
Sep 30, 2025 2.77 Mn
Jun 30, 2025 -5.54 Mn
Mar 31, 2025 9.24 Mn
Dec 31, 2024 5.26 Mn
Sep 30, 2024 405,000.00
Jun 30, 2024 -3.16 Mn
Mar 31, 2024 3.11 Mn
Dec 31, 2023 -854,000.00
Sep 30, 2023 8.19 Mn
Jun 30, 2023 -1.22 Mn
Mar 31, 2023 5.75 Mn
Dec 31, 2022 2.85 Mn
Sep 30, 2022 3.85 Mn
Jun 30, 2022 -1.07 Mn
Mar 31, 2022 2.68 Mn
Dec 31, 2021 754,000.00
Sep 30, 2021 837,000.00
API Access

Replimune Change in Accured Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-accured-expenses&ticker=REPL&period=max&api_key=YOUR_API_KEY